The global actigraphy device market is expanding rapidly as advancements in technology bring wearable, non-invasive devices to the forefront of sleep and health monitoring. With a projected market size of US$ 11,488.2 million by 2032, compared to US$ 2,520.0 million in 2025, this market is expected to experience a compound annual growth rate (CAGR) of 24.2% from 2025 to 2032. Persistence Market Research highlights key factors driving this growth, including the increasing prevalence of sleep disorders, lifestyle-related health issues, and the growing demand for convenient and accurate monitoring devices.
Actigraphy devices, once primarily used in sleep studies, are now being applied in a wide array of health sectors, including mental health, rehabilitation, and fitness. The devices are compact, wearable, and smart, making them convenient for long-term, non-invasive monitoring of human rest-activity cycles. As more individuals seek to improve their health, the demand for such devices is expected to continue to rise.
Key Highlights from the Report
➤ The actigraphy device market is projected to grow at a CAGR of 24.2% from 2025 to 2032.
➤ Wearable actigraphy devices dominate the market, with a forecast share of 58.4% in 2025.
➤ North America is predicted to lead the market in 2025, driven by high demand in sleep and mental health research.
➤ Sleep disorders are the leading application segment, accounting for approximately 29.6% of the market in 2025.
➤ Actigraphy devices are expanding their use in fitness centers and sports organizations for recovery and performance monitoring.
➤ The Asia Pacific market, especially Japan and China, is expected to witness significant growth in actigraphy adoption.
𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭
Market Overview and Statistics
The actigraphy device market has seen a steady rise in recent years. With the growing need for non-invasive monitoring solutions, the market has evolved from simple sleep studies to applications in broader healthcare, fitness, and mental health monitoring. Actigraphy devices measure movement patterns to infer rest-activity cycles, making them essential tools in understanding various health conditions, especially sleep disorders. According to Persistence Market Research, the market’s growth is largely driven by factors such as the rising global prevalence of sleep disorders and a growing emphasis on mental health.
The global actigraphy device market is set to witness a CAGR of 24.2% during the forecast period between 2025 and 2032. In terms of revenue, North America is expected to hold a significant share in 2025, primarily due to increasing demand for remote patient monitoring solutions. This is accompanied by the rising adoption of wearable technology, which offers substantial benefits for both clinical and home care settings.
Market Segmentation
Actigraphy devices can be classified into two primary segments based on product type: wearable and handheld devices. Wearable devices, such as wristbands or smartwatches, are expected to account for about 58.4% of the market in 2025. These devices offer continuous, non-invasive monitoring of sleep and activity patterns, making them popular for at-home usage. Additionally, their user-friendly design and ability to integrate into daily life further increase their appeal.
Handheld devices, while typically used in clinical settings, are also expected to grow due to their portability and ease of use. These devices are often used for short-term monitoring or during clinical trials where precise data collection is essential. Both product types benefit from advancements in data analytics, artificial intelligence (AI), and sensor technology, enhancing their ability to capture accurate health data.
Actigraphy devices are also categorized by application into three main segments: sleep disorders, physical activity monitoring, and chronic disease management. Sleep disorders dominate the market, accounting for 29.6% of the market share in 2025. These devices are highly effective in providing non-invasive monitoring of sleep-wake patterns, which is particularly useful for diagnosing sleep-related conditions such as insomnia, sleep apnea, and restless leg syndrome. The American Academy of Sleep Medicine (AASM) endorses actigraphy devices for both adult and pediatric patients.
Regional Insights
North America
North America is anticipated to lead the actigraphy device market, contributing approximately 36.2% of the total market share in 2025. The region’s dominance can be attributed to several factors, including the increasing reliance on wearable technology for sleep monitoring and the widespread adoption of remote patient monitoring systems. Key research institutions, hospitals, and sleep clinics in the U.S. are increasingly turning to actigraphy to conduct sleep studies and treat circadian rhythm disorders in non-clinical environments. Persistence Market Research highlights this trend, noting the surge in partnerships between actigraphy manufacturers and pharmaceutical companies to further research and development.
Europe
Europe, particularly countries like Germany and the Nordic nations, are seeing a rise in the adoption of actigraphy devices, especially in occupational health research. For example, studies conducted by the Karolinska Institute in Sweden have used actigraphy to assess the effects of night shifts on sleep patterns, which has led to discussions on improving labor policies. Additionally, the EU’s Medical Device Regulation (MDR) has prompted a consolidation of vendors, resulting in the emergence of companies offering CE-certified devices that comply with these stringent regulations.
Asia Pacific
The Asia Pacific region is witnessing rapid growth, particularly in Japan and China, due to increasing research into elderly health and the rising prevalence of sleep disorders. In Japan, the use of actigraphy devices is becoming common in geriatric studies, particularly to monitor cognitive function and physical activity in older adults. China, with its vast healthcare system, is also seeing significant adoption of these devices, particularly as domestic tech giants such as Huawei and Oppo incorporate actigraphy-style monitoring into their smartwatches.
Market Drivers
Rising Prevalence of Sleep Disorders
The global prevalence of sleep disorders is a significant factor driving the demand for actigraphy devices. With millions of people suffering from insomnia, sleep apnea, and other sleep-related conditions, there is an urgent need for reliable, non-invasive monitoring tools. Persistence Market Research suggests that actigraphy devices are ideal for home-based sleep monitoring, reducing the need for costly hospital visits and improving patient comfort.
Technological Advancements in Wearable Devices
Advancements in sensor technology, artificial intelligence (AI), and data analytics have further enhanced the capabilities of actigraphy devices. Modern actigraphy devices are now more accurate and capable of providing comprehensive data on sleep quality, activity levels, and overall health. These devices integrate seamlessly with mobile apps and cloud-based platforms, offering real-time health insights.
Increasing Focus on Health and Fitness
Fitness enthusiasts and athletes are increasingly turning to actigraphy devices to monitor their sleep quality, physical activity, and overall recovery. These devices help optimize performance by providing data on the ideal balance of rest, activity, and recovery. The growing popularity of fitness tracking devices from companies like Fitbit and Garmin is further driving market growth in the fitness sector.
Market Restraints
Limitations in Sleep Stage Accuracy
One of the major limitations of actigraphy devices is their reliance on movement to determine sleep-wake states. Unlike polysomnography, which records brain activity and eye movements to distinguish between sleep stages, actigraphy devices can only estimate the total sleep time. This limitation can lead to inaccurate results, particularly in individuals with fragmented sleep patterns, such as those with sleep apnea or insomnia.
High Cost of Advanced Devices
Although actigraphy devices offer cost-effective sleep monitoring solutions, the more advanced models can be expensive. For clinical settings, where hospital-grade devices are required, the cost can be a significant barrier. This may limit the adoption of these devices in resource-limited regions or smaller healthcare facilities.
Market Opportunities
Expansion into Fitness and Sports
Fitness centers and sports organizations are increasingly recognizing the potential of actigraphy devices for optimizing recovery and preventing injuries. These devices can help athletes track their sleep quality and physical activity levels, enabling them to optimize their training schedules. As more organizations look for ways to enhance athletic performance, the market for actigraphy devices in this segment is poised for growth.
Growing Demand in Geriatric Research
With an aging global population, there is an increasing demand for actigraphy devices in geriatric research. These devices provide valuable insights into the physical activity levels and sleep patterns of older adults, which are critical for improving their overall health. Countries with aging populations, such as Japan and Western Europe, present significant opportunities for manufacturers.
Reasons to Buy the Report
✔ Understand the key growth drivers propelling the actigraphy device market forward.
✔ Gain insights into the competitive landscape, including recent developments and strategies.
✔ Identify lucrative opportunities in emerging markets like Asia Pacific and fitness sectors.
✔ Discover the latest technological advancements in wearable actigraphy devices.
✔ Stay ahead of the curve with in-depth analysis of market segmentation and regional trends.
Company Insights
✦ ActiGraph, LLC
✦ ActivInsights Ltd.
✦ Koninklijke Philips N.V.
✦ Fibion Inc.
✦ neurocare group AG
✦ Empatica Inc.
✦ CamNtech Ltd.
✦ Cleveland Medical Devices
✦ SOMNOmedics AG
✦ Nox Medical
✦ Fitbit
✦ CIDELEC
Recent Developments
In October 2023, the American Academy of Sleep Medicine (AASM) unveiled the Act on Actigraphy campaign, emphasizing the growing importance of actigraphy for diagnosing sleep disorders. The initiative advocates for increased reimbursement from insurance companies for actigraphy testing, aiming to make these devices more accessible for widespread clinical use and to underscore their value in improving patient outcomes.
In November 2023, ActiGraph launched its next-generation wearable device, the ActiGraph LEAP, which provides continuous digital measures of mobility, sleep, physical activity, and other vital signs in a single, fit-for-purpose device. This innovation aims to streamline data collection for both clinical trials and real-world monitoring, offering researchers and healthcare providers enhanced insights into patient health.
Conclusion
The global actigraphy device market is set to experience robust growth over the next decade, driven by increasing healthcare demands, technological advancements, and rising awareness of sleep disorders and their impact on overall health. With a projected market value of US$ 11,488.2 million by 2032, the market’s expansion is being fueled by innovations in wearable technology, including smartwatches and fitness trackers, which are making it easier for individuals and healthcare providers to monitor sleep and activity patterns in real-time.
Persistence Market Research has highlighted that key market drivers, such as the growing prevalence of sleep disorders, advancements in AI-powered devices, and increasing adoption in fitness and geriatric research, will continue to accelerate market growth. However, challenges such as the limitations in sleep stage accuracy and the high costs of advanced clinical devices remain hurdles to wider adoption.
Read More Related Reports:
